Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(14%)
Results Posted
50%(2 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_3
1
14%
Ph phase_4
1
14%
Ph not_applicable
4
57%
Ph early_phase_1
1
14%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Terminated1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 31 (14.3%)
Phase 41 (14.3%)
N/A4 (57.1%)

Trials by Status

terminated114%
completed457%
recruiting114%
unknown114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
7